ClinicalTrials.Veeva

Menu

Clinical Outcomes of Percutaneous Nephrolithotomy Following Retrograde Percutaneous Nephrostomy Access Using Novel Device in Comparison to Antegrade Access

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Not yet enrolling

Conditions

Kidney Stone

Treatments

Device: antegrade nephrostomy
Device: retrograde nephrostomy

Study type

Interventional

Funder types

Other

Identifiers

NCT05022537
HSC-MS-20-1269

Details and patient eligibility

About

The purpose of this study is to compare relevant clinical outcomes in patients requiring percutaneous nephrostomy for urolithiasis treatment between those who undergo an antegrade approach versus a retrograde approach and to determine which clinical characteristics predict success of lithotomy with anterograde or retrograde percutaneous nephrostomy approaches.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

-Renal pelvis and proximal ureteral stones >10 mm confirmed with non-contrast computed tomography

Exclusion criteria

  • Suspected pyelonephritis.

  • Prior percutaneous nephrolithotomy procedure in affected kidney.

  • Mid-ureteral or distal ureteral stones.

  • Pregnancy.

  • Anatomical abnormal kidney, including:

    • Horseshoe
    • Ectopic

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Treatment (retrograde nephrostomy)
Experimental group
Treatment:
Device: retrograde nephrostomy
Control Group ( antegrade nephrostomy)
Active Comparator group
Treatment:
Device: antegrade nephrostomy

Trial contacts and locations

1

Loading...

Central trial contact

Amy Isidahomen; Nadeem N Dhanani, MD,MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems